Effects of arsenic on pyruvate dehydrogenase activation. by Schiller, C M et al.
Environmental Health Perspectives
Vol. 19, pp. 205-207, 1977
Effects ofArsenic on Pyruvate
Dehydrogenase Activation
by Carol M. Schiller,* Bruce A. Fowler,* and
James S. Woods*
Our studies illuminate a particular site of altered pyruvate utilization by liver mitochondria isolated
from arsenic-fed rats. Initially, pyruvate dehydrogenase (PDH) levels were measured before and after in
vitro activation. The liver homogenates were prepared from male rats given access to deionized drinking
water solutions containing 0, 20, 40, and 85 ppm arsenic as sodium arsenate (As+5) for 3 and 6 weeks.
After 3 weeks, the effects ofarsenic at the highest dose level were pronounced onthe basal activity (before
activation), with inhibition up to48% ofthe control values. The total PDH (after activation) was inhibited
by 14, 15, and 28%o of the control values at 20, 40, and 85 ppm As+5, respectively. A similar pattern of
inhibition of PDH was observed at 6 weeks, although the inhibition was lower at the highest dose. This
effect is probably a reflection ofmitochondrial regeneration at this time and dose. The inhibition ofPDH
both before and after activation suggests a direct arsenic effect on pyruvate utilization which does not
involve a lipoic acid moiety. Evidence is also presented which indicates an arsenic effect on the regulating
kinase and/or phosphatase. The metabolic effects ofimpaired mitochondrial utilization by pyruvate are
also discussed.
Introduction
Arsenic fed to laboratory animals is known to
accumulate in the mitochondria which has been re-
lated to the swelling ofthis subcellular organelle in a
number of tissues especially the liver (1). In vitro
research has demonstrated that arsenic affects
mitochondrial oxidations by causing oligomycin-
sensitive stimulation of oxidation in the absence of
inorganic phosphate (2, 3) and by stimulating the
mitochondrial ATPase (4). More recently,
mitochondrial respiration studies, with liver
mitochondria isolated from rats chronically ex-
posed to arsenic, indicated decreased state 3 respi-
ration rates and decreased respiratory control ratios
for pyruvate/malate- but not succinate-mediated res-
piration (1).
It has been suggested that the effects of arsenic
on mitochondrial pyruvate utilization results from
arsenic binding to the lipoic acid and dithiol
moieties ofthe PDH complex (5). The initial step in
the mitochondrial metabolism ofpyruvate, which is
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catalyzed by this multienzyme complex, involves
the formation of acetyl-CoA and the generation of
CO2 and NADH. This complex is composed of
three enzymes: pyruvate decarboxylase (pyruvate
dehydrogenase), dehydrolipoate transacetylase,
and dihydrolipoate dehydrogenase. It is the second
two enzymes which involve active dithiol moieties.
The first enzyme of the complex is regulated by
inactivation and activation reactions, which are
controlled by a phosphorylation/dephosphorylation
mechanism (6, 7). Thus, phosphorylation and the
concomitant inactivation of PDH [Eq. (1)] is
catalyzed by a MgATP-requiring kinase, and' de-
phosphorylation and concomitant reactivation is
catalyzed by a Mg- and Ca-requiring phosphatase
(6-10). In order to examine whether or not this
phosphorylation/dephosphorylation mechanism
was a site ofaction for arsenic, PDH levels, before
and,after in vitro activation, were measured in tis-
sue from arsenic-fed animals.
Kinase
PDHa
active
(unphosphorylated)
Phosphatase
PDHb
inactive
(phosphorylated)
(1)
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Chemicals
Cofactors and substrates were obtained from
Boehringer-Mannheim, New York. The
radiochemical sodium [1- "4C]-pyruvate was ob-
tained from New England Nuclear, Boston.
Animals
The adult male Charles River CD rats used in
this experiment were given access to acasein-based
purified diet and to deionized drinking water con-
taining 0, 20, 40, and 85 ppm arsenic as sodium
arsenate (As+5) for 3 and 6 weeks. The animals
were decapitated and hepatic tissue was excised
quickly and dropped into liquid nitrogen. The fro-
zen tissue samples were weighed and homogenized
in ice cold buffer.
AssayofPyruvate Dehydrogenase
The PDH activities were determined by the
stoichiometric release of radioactive CO2 from [1-
4C]-pyruvate by the method previously described
(11). This assay method was linear with time and
protein concentration within the ranges utilized.
The optimal in vitro activation conditions for PDH
were determined to be exposure to 75mM MgCl2 at
37°C for 5 min. Aliquots ofeach tissue homogenate
were assayed before and after Mg activation to de-
termine the basal and total PDH activities, respec-
tively.
Protein Analysis
Total protein concentrations in the homogenates
were determined by procedures previously de-
scribed (12).
No mortality occurred among any of the treated
animals during the course of the exposure to arse-
nic. A significant depression ofgrowth rate was ob-
served only among the animals exposed to the 85
ppm As+5 dose (1).
The exposure of rats to arsenic for three weeks
resulted in a decrease in both the basal and total
hepatic PDH activities, as shown in Table 1. The
effects on the basal levels of PDH activity as com-
pared to the controls indicated an increasing inhibi-
tion with dose level of 20, 23, and 48%. The total
PDH levels were also lower, but by a smaller
amount, i.e., 14, 15, and 28% (Table 1).
Table 1. Inhibition of rat liver pyruvate dehydrogenase activity
after 3 weeks exposure to arsenate in drinking water.
Pyruvate dehydrogenase,
As5+ % inhibitiona
ppm Basal Total
0 0 0
20 20.0 13.5
40 22.5 15.3
85 47.5 27.6
aBasal and total refer to the enzyme activity before and after in
vitro activation.
The PDH activity expressed as nmoles of CO2
liberated (pyruvate utilized) per minute per mg of
protein is shown in Table 2. The derived data in
Table 2 illustrate another effect of arsenic. There
was a decrease in the basal/total ratio with increas-
ing arsenic dose level. The difference between the
total and basal was relatively constant with increas-
ing arsenic dose level. The ratio ofthe difference to
the basal level went up markedly with increasing
dose level, indicating the relative ease ofactivation
increases with increasing dose level.
The effects after 6 weeks of arsenic exposure
were inhibition of basal and total PDH activity.
However, as shown in Table 3, this inhibition was
not observed at the highest dose level.
Table 2. Rat liver pyruvate dehydrogenase activity after 3 weeks exposure to arsenate in drinking water.a
Pyruvate dehydrogenase,
As5', nmole/min-mg Activation, Difference
ppm Basal Total % (basal/total) (total - basal) Difference/basal
0 2.84 ± 0.28 5.03 ± 0.87 60.1 ± 12.3 2.19 ± 0.99 0.82 ± 0.38
20 2.27 ± 0.45 4.34 ± 0.61 51.5 ± 7.7 2.07 ± 0.47 1.34 ± 0.40
40 2.20 ± 0.34 4.26 ± 0.66 49.9 ± 8.2 2.19 ± 0.45 1.39 ± 0.38
85 1.49 ± 0.30 3.64 ± 0.54 42.4 ± 5.9 2.15 ± 0.41 1.80 ± 0.43
aValues are the means ± SEM for nine separate animals. Assays were performed in triplicate.
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after 6 weeks exposure to arsenate in drinking water.
Pyruvate dehydrogenase,
As + % inhibition
ppm Basal Total
0 0 0
20 24.7 40.0
40 33.0 43.0
85 2.3 9.9
Discussion
This investigation illustrates adose-related effect
of arsenic on PDH activity after three weeks of
exposure. The effect is characterized by a gradual
decrease in basal PDH activity, agradual decrease
in total PDH activity and an increase in relative
ease in activation with increase in dose level. This
last effect may be indicative ofa stimulation ofthe
phosphatase, an inhibition of the kinase and/or an
effect directly on the pyruvate decarboxylase. Al-
though inhibition ofbothbasalandtotal PDH activ-
ity was observed after 6 weeks exposure at the
lower doses, at the highest dose there was not
marked inhibition. Thispattern ofinhibition may be
indicative of mitochondrial regeneration at this
highest dose after six weeks.
The reaction involving the phosphatase and the
kinase are illustrated by Eq. (2).
El + Ek
- X-E1 X + Ek
El + Ep
- X +-El
- X + Ep (2)
Here E1 denotes PDH, Ek is kinase, E, is phos-
phatase, and X denotes Pi or As1. The active E1
(PDH) is phosphorylated by Ek
- X. The inactive
El
- X complex that forms is reactivated by Ep,
which removes the phosphate group to form E1 and
Ep
- X. Thus, at some time, each of the three en-
zymes must bind to a phosphate moiety. By anal-
ogy, arsenate may bind to any or all of these en-
zymes and thus interfere with the PDH activity di-
rectly or the regulation of PDH activity.
The possible metabolic effects of this inhibition
ofPDH activity are illustrated in Figure 1. IfPDH
activity is substantially inhibited, there will be a
decrease in acetyl-CoA formation which leads to a
decrease in carbon flow through the tricarboxylic
acid cycle. This decreased flow leads to adecrease
in NADH generated for ATP formation via the
electron-transport chain. Also, there will be a de-
crease in the citrate available to leave the
mitochondria to supply acetyl-CoA for fatty acid
synthesis. In turn, the pyruvate not utilized by the
glucos glucose - so so pyruvate - klctate
pyruvate
OAA CoA
(TCA) dflrte citrate
(FAS)
FIGURE 1. Schematic illustration ofthe flow ofglucose metabo-
lites into the mitochondnia. TCA = tricarboxylic acid cycle,
FAS = fatty acid synthesis.
mitochondria will probably spill back into the
cytosol and be converted to lactate.
Thus, the observed effects on mitochondrial
metabolism of pyruvate would support previous in
vitro mitochondrial studies which indicate poor
utilization of pyruvate/malate compared to succi-
nate. Also, the probable decrease in availability of
citrate for the synthesis offatty acids would in turn
result in less storage triglycerides.
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